▶ 調査レポート

世界の体外診断市場2021年ー2028年:技術種類別(ポイントオブケア、分子診断、免疫測定法、臨床化学、全血糖監視、血液、臨床微生物、凝固・ヘモスタシス、その他)、用途別、エンドユーザー別

• 英文タイトル:In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infectious Diseases, Oncology, Metabolic Diseases, Autoimmune Diseases, and Others; and End-user: Diagnostic Laboratories, Hospitals, Academic & Research Centers, Home Care, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Transparency Market Researchが調査・発行した産業分析レポートです。世界の体外診断市場2021年ー2028年:技術種類別(ポイントオブケア、分子診断、免疫測定法、臨床化学、全血糖監視、血液、臨床微生物、凝固・ヘモスタシス、その他)、用途別、エンドユーザー別 / In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infectious Diseases, Oncology, Metabolic Diseases, Autoimmune Diseases, and Others; and End-user: Diagnostic Laboratories, Hospitals, Academic & Research Centers, Home Care, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 / MRC2204A110資料のイメージです。• レポートコード:MRC2204A110
• 出版社/出版日:Transparency Market Research / 2022年2月
• レポート形態:英文、PDF、222ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界の体外診断市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、用途別(薬物検査、感染症、腫瘍、代謝性疾患、自己免疫疾患)分析、エンドユーザー別分析、技術種類別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の体外診断市場規模:用途別(薬物検査、感染症、腫瘍、代謝性疾患、自己免疫疾患)
・世界の体外診断市場規模:エンドユーザー別
・世界の体外診断市場規模:技術種類別
・世界の体外診断市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

In Vitro Diagnostics Market – Scope of Report
TMR’s report on the global in vitro diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global in vitro diagnostics market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro diagnostics market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in vitro diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global in vitro diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro diagnostics market.

The report delves into the competition landscape of the global in vitro diagnostics market. Key players operating in the global in vitro diagnostics market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro diagnostics market profiled in this report.

Key Questions Answered in Global In Vitro Diagnostics Market Report
What will be the revenue generated in the global in vitro diagnostics market across all geographies during the forecast period?
What are key trends in the in vitro diagnostics market?
What are major drivers, restraints, and opportunities in the market?
Which region is set to expand at the maximum CAGR during the forecast period?
Which segment of the global in vitro diagnostics market will generate the maximum revenue globally by 2028?
Which segment will expand at the maximum CAGR during the forecast period?
In Vitro Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global in vitro diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vitro diagnostics market in terms of technology type, application, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro diagnostics market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Diagnostics Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Mergers and Acquisition
5.2. Key Success Factor for Top 3 Players
5.3. Regulatory Scenario
5.4. Technology Assessment
6. Global In Vitro Diagnostics Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Application, 2017–2028
6.3.1. Drug Testing
6.3.2. Infectious Diseases
6.3.3. Oncology
6.3.4. Metabolic Diseases
6.3.5. Autoimmune Diseases
6.3.6. Others
6.4. Market Attractiveness Analysis, by Application
7. Global In Vitro Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2028
7.3.1. Diagnostic Laboratories
7.3.2. Hospitals
7.3.3. Academic & Research Centers
7.3.4. Home Care
7.3.5. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Diagnostics Market Analysis and Forecast, by Technology Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Technology Type, 2017–2028
8.3.1. Point-of-care
8.3.2. Molecular Diagnostics
8.3.3. Immunoassays
8.3.4. Clinical Chemistry
8.3.5. Whole Blood Glucose Monitoring
8.3.6. Hematology
8.3.7. Clinical Microbiology
8.3.8. Coagulation & Hemostasis
8.3.9. Others
8.4. Market Attractiveness Analysis, by Technology Type
9. Global In Vitro Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America In Vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Application, 2017–2028
10.2.1. Drug Testing
10.2.2. Infectious Diseases
10.2.3. Oncology
10.2.4. Metabolic Diseases
10.2.5. Autoimmune Diseases
10.2.6. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2028
10.3.1. Diagnostic Laboratories
10.3.2. Hospitals
10.3.3. Academic & Research Centers
10.3.4. Home Care
10.3.5. Others
10.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
10.4.1. Point-of-care
10.4.2. Molecular Diagnostics
10.4.3. Immunoassays
10.4.4. Clinical Chemistry
10.4.5. Whole Blood Glucose Monitoring
10.4.6. Hematology
10.4.7. Clinical Microbiology
10.4.8. Coagulation & Hemostasis
10.4.9. Others
10.5. Market Value & Volume Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By End-user
10.6.3. By Technology Type
10.6.4. By Country
11. Europe In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Application, 2017–2028
11.2.1. Drug Testing
11.2.2. Infectious Diseases
11.2.3. Oncology
11.2.4. Metabolic Diseases
11.2.5. Autoimmune Diseases
11.2.6. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2028
11.3.1. Diagnostic Laboratories
11.3.2. Hospitals
11.3.3. Academic & Research Centers
11.3.4. Home Care
11.3.5. Others
11.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
11.4.1. Point-of-care
11.4.2. Molecular Diagnostics
11.4.3. Immunoassays
11.4.4. Clinical Chemistry
11.4.5. Whole Blood Glucose Monitoring
11.4.6. Hematology
11.4.7. Clinical Microbiology
11.4.8. Coagulation & Hemostasis
11.4.9. Others
11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By End-user
11.6.3. By Technology Type
11.6.4. By Country/Sub-region
12. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Application, 2017–2028
12.2.1. Drug Testing
12.2.2. Infectious Diseases
12.2.3. Oncology
12.2.4. Metabolic Diseases
12.2.5. Autoimmune Diseases
12.2.6. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2028
12.3.1. Diagnostic Laboratories
12.3.2. Hospitals
12.3.3. Academic & Research Centers
12.3.4. Home Care
12.3.5. Others
12.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
12.4.1. Point-of-care
12.4.2. Molecular Diagnostics
12.4.3. Immunoassays
12.4.4. Clinical Chemistry
12.4.5. Whole Blood Glucose Monitoring
12.4.6. Hematology
12.4.7. Clinical Microbiology
12.4.8. Coagulation & Hemostasis
12.4.9. Others
12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By End-user
12.6.3. By Technology Type
12.6.4. By Country/Sub-region
13. Latin America In Vitro Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Application, 2017–2028
13.2.1. Drug Testing
13.2.2. Infectious Diseases
13.2.3. Oncology
13.2.4. Metabolic Diseases
13.2.5. Autoimmune Diseases
13.2.6. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2028
13.3.1. Diagnostic Laboratories
13.3.2. Hospitals
13.3.3. Academic & Research Centers
13.3.4. Home Care
13.3.5. Others
13.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
13.4.1. Point-of-care
13.4.2. Molecular Diagnostics
13.4.3. Immunoassays
13.4.4. Clinical Chemistry
13.4.5. Whole Blood Glucose Monitoring
13.4.6. Hematology
13.4.7. Clinical Microbiology
13.4.8. Coagulation & Hemostasis
13.4.9. Others
13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By End-user
13.6.3. By Technology Type
13.6.4. By Country/Sub-region
14. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Application, 2017–2028
14.2.1. Drug Testing
14.2.2. Infectious Diseases
14.2.3. Oncology
14.2.4. Metabolic Diseases
14.2.5. Autoimmune Diseases
14.2.6. Others
14.3. Market Value & Volume Forecast, by End-user, 2017–2028
14.3.1. Diagnostic Laboratories
14.3.2. Hospitals
14.3.3. Academic & Research Centers
14.3.4. Home Care
14.3.5. Others
14.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
14.4.1. Point-of-care
14.4.2. Molecular Diagnostics
14.4.3. Immunoassays
14.4.4. Clinical Chemistry
14.4.5. Whole Blood Glucose Monitoring
14.4.6. Hematology
14.4.7. Clinical Microbiology
14.4.8. Coagulation & Hemostasis
14.4.9. Others
14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By End-user
14.6.3. By Technology Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Application Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. Competition Matrix
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. F. Hoffmann-La Roche Ltd.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. Danaher
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Siemens Healthineers
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. bioMérieux SA
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Abbott
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Diasorin
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Meridian Bioscience, Inc.
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
15.5.9. Ortho-Clinical Diagnostics, Inc.
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Product Portfolio
15.5.9.3. SWOT Analysis
15.5.9.4. Strategic Overview
15.5.10. Thermo Fisher Scientific, Inc.
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Product Portfolio
15.5.10.3. SWOT Analysis
15.5.10.4. Strategic Overview
15.5.11. Sysmex Corporation
15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.11.2. Product Portfolio
15.5.11.3. SWOT Analysis
15.5.11.4. Strategic Overview
15.5.12. Other Prominent Players
15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.12.2. Product Portfolio
15.5.12.3. SWOT Analysis
15.5.12.4. Strategic Overview

List of Table

Table 01: Global In Vitro Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Technology Type, 2021–2028

Table 02: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 03: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 04: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 05: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Application, 2021–2028

Table 06: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 07: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Region, 2021–2028

Table 08: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country 2021–2028

Table 09: North America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 10: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 11: America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 12: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 13: North America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 14: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 15: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 16: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 17: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 18: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 19: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 20: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 21: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 22: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 23: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 24: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 25: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 26: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 27: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 28: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 29: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 30: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 31: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 32: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 33: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 34: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 35: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028

Table 36: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028

Table 37: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028

Table 38: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028

Table 39: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028

Table 40: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028

Table 41: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028

Table 42: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028